NeuroTrax is a company focused on brain health, operating in the healthcare and technology sectors. The company offers a computerized testing solution, BrainCare, which provides objective tests across various cognitive areas, graphical reports of patient progress, and evidence-based recommendations for brain training to promote wellness. The primary customers of NeuroTrax are clinicians, patients and their families, and researchers in the healthcare industry. It was founded in 2000 and is based in Newark, New Jersey.
Latest NeuroTrax News
Jul 12, 2014
, Ctb/Mc Graw Hill, GL Assessments, Impact, Lumosity, Neurosky, Neurotrax, Pearson Assessments, Posit Science and The Cognition Group . Key innovators mentioned in this research are Anthrotronix, Beemedic, Emotiv, Happy Neuron, Neuroscan, Play Attention, Smart Brain Technologies and Vivity Labs ( ). Order a copy of this report at http://www.lifescienceindustryresearch.com/purchase?rname=7785. Solution providers such as Pearson Assessments, Cogstate , Cambridge Cognition , Lumosity, Posit Science, Bracket Global, CNS Vital Signs and many others are expected to continue to leverage opportunities across multiple regions via providing innovative cognitive assessment and training solutions. End customers, medical practitioners, and educational professionals will remain the major market for cognitive assessment and training solutions. Majority of the challenges in this market are specific to the constant research required and increasing need for tests in multiple languages because in order to build tests that can cater to verticals such as healthcare, education, pharmaceutical, as well as for applications such as cognitive training, employers' assessment and training, uninterrupted funding in research is needed to build and improve tests, which are adaptable and can give flawless subjective results and recommendations to each individual. Also, for companies catering to sectors such as healthcare, education, pharmaceutical, and HR, global expansion on a large scale is only possible if they have a portfolio of tests present in multiple languages so that they can cater to specific requirements of each individual or organization present anywhere across the globe. The report will help the market leaders/new entrants in this market in the following ways: This report segments the market into products and applications, covering this market comprehensively. The report provides the closest approximations of the revenue numbers for the overall market and the sub-segments. The market numbers are further split across the different verticals and regions. This report will help them better understand the competitor and gain more insights to better position their business. There is a separate section on competitive landscape, including competitor ecosystem, mergers and acquisition and venture capital funding. Besides, there are company profiles of top players in this market. In this section, market internals are provided that can put them ahead of the competitors. The report helps them understand the pulse of the market. The report provides information on key market drivers, restraints, and opportunities. Not ready to buy yet? Get your questions answered at http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=7785 before making a purchase decision on the report 'Cognitive Assessment and Training Market [Dementia Screening; Clinical Trials, Classroom Learning, Brain Training, Cognitive Abilities Test (CogAT, CAT), Concussion Management, Academic Research ] Worldwide Market Forecasts and Analysis (2013-2018)'. Explore more reports on the healthcare industry at http://www.lifescienceindustryresearch.com/category/healthcare. About Us: brings to you to the latest reports in market research on biotechnology, diagnostics, healthcare, medical devices and pharmaceuticals segments from leading research publishers across the globe. Read the full story at http://www.prweb.com/releases/cognitive-assessment-and/training-market-2018-data/prweb12011942.htm (c) 2014 PRWEB.COM Newswire
NeuroTrax Frequently Asked Questions (FAQ)
When was NeuroTrax founded?
NeuroTrax was founded in 2000.
Where is NeuroTrax's headquarters?
NeuroTrax's headquarters is located at 211 Warren Street, Newark.
What is NeuroTrax's latest funding round?
NeuroTrax's latest funding round is Incubator/Accelerator.
Who are the investors of NeuroTrax?
Investors of NeuroTrax include The Enterprise Development Center.
Who are NeuroTrax's competitors?
Competitors of NeuroTrax include Moximed, Cerapedics, RxSight, Lensar , Promedtek and 7 more.
Compare NeuroTrax to Competitors
C2C is a medical device company developing a portfolio of medical devices.
CeloNova BioSciences is a global medical device company that develops, manufactures and markets a family of interventional cardiology and endovascular products, including its proprietary COBRA PzF Coronary Stent System. The company's interventional cardiology and endovascular products are currently available in more than fifty countries.
Precision Light is a stealth-mode medical device company
Verifica BG is a medical device making company.
BiO2 Medical is a medical device manufacturer founded to design, develop, and manufacture a range of medical products in response to clinical needs. BiO2 Medical's current primary objective is to develop and commercialize the Angel Catheter for the prevention of Pulmonary Embolism related mortality and morbidity in critically ill patients worldwide.
synecor is a medical device developer